Lakeside Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Lakeside Advisors's AMGN Position: Q3 2026 in Review
Lakeside Advisors increased its Amgen (AMGN) stake by 0.15% in Q3 2026, buying an estimated $797 and bringing the position to 1,348 shares worth $568K. The position accounts for 0.33% of the portfolio, ranked #47.
Lakeside Advisors first reported a position in AMGN in Q4 2021 and has held it in 20 quarters since. 2,617 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Lakeside Advisors held 1,348 shares of Amgen worth $568K as of Q3 2026.
- Lakeside Advisors bought 2 Amgen shares in Q3 2026, an estimated $797.
- Amgen made up 0.33% of Lakeside Advisors's portfolio in Q3 2026, its #47 holding.
- Lakeside Advisors first reported a position in Amgen in Q4 2021 and has held it in 20 quarters since.
- 2,617 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Lakeside Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.